Cell Source

Cell Source Cell Source Inc. (OTCQB: CLCS) Our mission is to revolutionize the fields of transplantation, cancer treatment and reversal of vital organ disease.

Cell Source (OTCQB: CLCS) is a biotechnology company focused on developing cell therapy treatments based on the management of immune tolerance. The company’s patented "Veto-Cell" technology represents a major breakthrough in immune system management - safe and selective “tolerizing” of immune response. This technology addresses one of the most fundamental challenges in human immunology: how to tu

ne immune response so that it tolerates specific “desirable” foreign cells while continuing to attack all other potential threats. Revolutionizing transplantation, cancer treatment and reversal of vital organ disease, utilizing our breakthrough immune tolerance and organ regeneration technologies, with the prospect of saving the lives of hundreds of thousands of people.

Address

57 W 57th St, Ste 400
New York, NY
10019

Telephone

(646) 416-7896

Website

Alerts

Be the first to know and let us send you an email when Cell Source posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category